Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02037789 · ClinicalTrials.gov registry record
A Retrospective Study to Identify New "Omics" Biomarkers of Chronic/Persistent Low Back Pain
A clinical trial of Persistent/Chronic Low Back Pain, sponsored by University of Parma.
- Completed
- Registry status
- 6
- Study locations
NCT02037789 is a study of Persistent/Chronic Low Back Pain that has completed, run by University of Parma. The trial reports 6 study locations across 2 states.
The verdict
NCT02037789, a study of Persistent/Chronic Low Back Pain, has completed, sponsored by University of Parma.
- COMPLETED
- Registry status
- 6
- Study locations
Study Summary
Low back pain (LBP) is one of the most common medical problems encountered in daily life; it is related to disability and work absence and accounts for high economical costs in Western societies. Low-back pain is a diverse group of mixed pain syndromes (neuropathic and nociceptive) with different molecular pathologies at different structural levels displaying similar clinical manifestations. Currently, there are limited biomarkers (mostly imaging) or clinical findings that can be used objectively to help the physician in precise anatomic diagnosis leading to the safest and most cost-effective treatment for the patient (reduction of direct and indirect costs and improvement of treatment efficacy). The main aim of this trial is to identify all "omics biomarkers" associated with susceptibility to chronic/persistent LBP and its different pathophysiology.
Conditions Studied
Study Locations (6)
Other
- Edith Cowan University (ECU) - Perth
- Multidisciplinary Pain Centre, Hospital Oost-Limburg (ZOL) - Genk
- "St.Catharine" Orthopedics, Surgery, Neurology and Physical Medicine and Rehabilitation Specialty Hospital (St-Cat) - Zabok
- Anesthesia and Pain Therapy Department, Università degli Studi di Parma (UNIPR) - Parma
- Fondazione IRCCS Policlinico San Matteo (OSM) - Pavia
North Carolina
- The Center for Clinical Research (CPI) - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Start Date | 2014-03 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02037789
The ClinicalTrials.gov registry entry for NCT02037789 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Parma, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent/Chronic Low Back Pain appearing as the primary indexed condition, and to 0 interventions.
NCT02037789 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Other, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02037789 about?
NCT02037789 is a clinical study titled "A Retrospective Study to Identify New "Omics" Biomarkers of Chronic/Persistent Low Back Pain". Low back pain (LBP) is one of the most common medical problems encountered in daily life; it is related to disability and work absence and accounts for high economical costs in Western societies. Low-back pain is a diverse group of mixed pain syndromes (neuropathic and nociceptive) with different m...
What is the current status of trial NCT02037789?
This trial is currently completed. The study started on 2014-03. Estimated completion is 2016-02.
What conditions does trial NCT02037789 study?
This clinical trial studies the following conditions: Persistent/Chronic Low Back Pain.
Who is sponsoring clinical trial NCT02037789?
This trial is sponsored by University of Parma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02037789 being conducted?
This trial has 6 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.